CHERYL ADKINSON: Open Payments
NPI 1013658137 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,934 in 92 payments from 13 companies in 2025. Trend: 2023 $833 · 2024 $2,261 · 2025 $2,934
Food & beverage: $2,823Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $483 |
| Teva Pharmaceuticals USA, Inc. | 16 | $466 |
| Vanda Pharmaceuticals Inc. | 9 | $307 |
| E.R. Squibb & Sons, L.L.C. | 8 | $274 |
| Axsome Therapeutics, Inc. | 5 | $244 |
| Otsuka America Pharmaceutical, Inc. | 12 | $229 |
| Supernus Pharmaceuticals, Inc. | 10 | $209 |
| Neurocrine BioSciences, Inc. | 4 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $176 |
| Collegium Pharmaceutical, Inc. | 1 | $124 |
Products named: VRAYLAR, UZEDY, FANAPT, COBENFY, Auvelity, Qelbree, INGREZZA, CAPLYTA.
Industry payments across FL — which companies pay providers there.
